|
JPH09504000A
(ja)
*
|
1993-08-11 |
1997-04-22 |
ジェナー テクノロジーズ |
前立腺癌ワクチン
|
|
US20010036928A1
(en)
*
|
1996-04-22 |
2001-11-01 |
Chamberlain Ronald S. |
Heterologous boosting immunizations
|
|
US6969609B1
(en)
|
1998-12-09 |
2005-11-29 |
The United States Of America As Represented By The Department Of Health And Human Serivces |
Recombinant vector expressing multiple costimulatory molecules and uses thereof
|
|
US7148035B1
(en)
|
1998-11-18 |
2006-12-12 |
Oxford Biomedica (Uk) Limited |
Polypeptide
|
|
DE69924826T8
(de)
*
|
1998-11-18 |
2008-09-25 |
Oxford Biomedica (Uk) Ltd. |
Verwendung vom krebs-assoziierten antigen 5t4 zur immuntherapie
|
|
CA2354024C
(en)
*
|
1998-12-09 |
2009-12-22 |
Jeffrey Schlom |
A recombinant vector expressing multiple costimulatory molecules and uses thereof
|
|
EP1865065A1
(en)
*
|
1998-12-09 |
2007-12-12 |
The Government of the United States of America, as represented by the Secretary, Department of Health and Human Services |
A recombinant vector expressing multiple costimulatory molecules and uses thereof
|
|
US7786278B2
(en)
*
|
2002-04-09 |
2010-08-31 |
Sanofi Pasteur Limited |
Modified CEA nucleic acid and expression vectors
|
|
WO2005019464A1
(en)
*
|
2003-08-21 |
2005-03-03 |
Virax Development Pty Ltd |
Poxvirus vector encoding prostate specific antigens for treatment of prostate cancer
|
|
DE602004032365D1
(de)
*
|
2003-10-08 |
2011-06-01 |
Sanofi Pasteur Inc |
Modifizierter cea/b7-vektor
|
|
CA2545164C
(en)
*
|
2003-11-12 |
2016-11-29 |
The Government Of The United States Of America, As Represented By The Department Of Health And Human Services |
Recombinant vectors expressing mucin and carcinoembryoinic antigen
|
|
JP5285855B2
(ja)
|
2003-11-12 |
2013-09-11 |
アメリカ合衆国 |
膵癌を処置および予防するためのカスタムベクター
|
|
CA2744294A1
(en)
|
2009-01-13 |
2010-07-22 |
Transgene Sa |
Use of a saccharomyces cerevisiae mitochondrial nucleic acids fraction for immune stimulation
|
|
PT2382474E
(pt)
|
2009-01-20 |
2015-06-03 |
Transgene Sa |
Icam-1 solúvel como biomarcador para a previsão de uma resposta terapêutica
|
|
WO2010108908A1
(en)
|
2009-03-24 |
2010-09-30 |
Transgene Sa |
Biomarker for monitoring patients
|
|
CN102395883B
(zh)
|
2009-04-17 |
2015-12-02 |
特朗斯吉有限公司 |
用于监控患者的生物标志物
|
|
CN102483405B
(zh)
|
2009-07-10 |
2015-12-02 |
特朗斯吉有限公司 |
用于选择患者的生物标志物及相关方法
|
|
CA2807514A1
(en)
|
2010-08-06 |
2012-02-09 |
The United States Of America, As Represented By The Secretary, Departmen T Of Health And Human Services |
Biomarkers for prostate cancer and methods for their detection
|
|
US9725494B2
(en)
*
|
2013-05-17 |
2017-08-08 |
United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Soluble CD27 (sCD27) and the use thereof
|
|
WO2015069571A1
(en)
*
|
2013-11-05 |
2015-05-14 |
Bavarian Nordic, Inc. |
Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and an antagonist and/or agonist of an immune checkpoint inhibitor
|
|
AU2015259516B2
(en)
|
2014-05-13 |
2020-05-28 |
Bavarian Nordic A/S |
Combination therapy for treating cancer with a poxvirus expressing a tumor antigen and a monoclonal antibody against TIM-3
|
|
DK3169340T3
(da)
|
2014-07-16 |
2020-11-09 |
Roussy Inst Gustave |
Kombination af onkolytisk virus med immun-checkpoint-modulatorer
|
|
EP3256156B1
(en)
|
2015-02-13 |
2025-02-12 |
Transgene |
Immunotherapeutic vaccine and antibody combination therapy
|
|
DK3329016T3
(da)
|
2015-07-31 |
2022-01-10 |
Bavarian Nordic As |
Promotorer til forbedring af ekspression i poxvirus
|
|
EP3400009A2
(en)
|
2016-01-05 |
2018-11-14 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Combination of histone deacetylase inhibitor and immunotherapy
|
|
US10822415B2
(en)
|
2016-01-28 |
2020-11-03 |
Inserm (Institut National De La Santéet De La Recherche Médicale) |
Methods for enhancing the potency of the immune checkpoint inhibitors
|
|
WO2017136342A1
(en)
|
2016-02-02 |
2017-08-10 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Fulvestrant for inducing immune-mediated cytotoxic lysis of cancer cells
|
|
CA3023022A1
(en)
|
2016-05-04 |
2017-11-09 |
Transgene Sa |
Combination therapy with cpg tlr9 ligand
|
|
AU2017336269B2
(en)
|
2016-09-28 |
2022-06-16 |
Bavarian Nordic A/S |
Compositions and methods for enhancing the stability of transgenes in poxviruses
|
|
EP3522920A2
(en)
|
2016-10-10 |
2019-08-14 |
Transgene SA |
Immunotherapeutic product and mdsc modulator combination therapy
|
|
WO2018091680A1
(en)
|
2016-11-18 |
2018-05-24 |
Transgene Sa |
Cowpox-based oncolytic vectors
|
|
JP7110203B2
(ja)
|
2016-12-28 |
2022-08-01 |
トランジェーヌ |
腫瘍溶解性ウイルスおよび治療用分子
|
|
BR112019021520A2
(pt)
|
2017-04-14 |
2020-08-04 |
Tollnine, Inc. |
oligonucleotídeo, composto, polinucleotídeo imunomodulador, composição, conjugado, método para modular um receptor, método de tratamento de um tumor, método de tratamento de câncer, método para tratar um tumor, método de prevenção de câncer, método para induzir uma resposta imune
|
|
WO2018211419A1
(en)
|
2017-05-15 |
2018-11-22 |
Janssen Vaccines & Prevention B.V. |
Stable virus-containing composition
|
|
AU2018269319A1
(en)
|
2017-05-15 |
2019-11-07 |
Janssen Vaccines & Prevention B.V. |
Stable virus-containing composition
|
|
WO2019020543A1
(en)
|
2017-07-28 |
2019-01-31 |
Transgene Sa |
ONCOLYTIC VIRUSES EXPRESSING AGENTS TARGETING METABOLIC IMMUNE MODULATORS
|
|
CA3073310A1
(en)
|
2017-08-24 |
2019-02-28 |
Bavarian Nordic A/S |
Combination therapy for treating cancer with an intravenous administration of a recombinant mva and an antibody
|
|
AU2019229653B2
(en)
|
2018-03-07 |
2025-09-11 |
Transgene |
Parapoxvirus vectors
|
|
WO2020011754A1
(en)
|
2018-07-09 |
2020-01-16 |
Transgene |
Chimeric vaccinia viruses
|
|
EP3847246A1
(en)
|
2018-09-06 |
2021-07-14 |
Bavarian Nordic A/S |
Storage improved poxvirus compositions
|
|
WO2020240024A1
(en)
|
2019-05-29 |
2020-12-03 |
Université De Tours |
Toxoplasma platform for treating cancer
|
|
MX2022010515A
(es)
|
2020-02-28 |
2022-11-14 |
Tallac Therapeutics Inc |
Conjugacion mediada por transglutaminasa.
|
|
AU2021233167A1
(en)
|
2020-03-12 |
2022-09-22 |
Bavarian Nordic A/S |
Compositions improving poxvirus stability
|
|
CN120380015A
(zh)
|
2022-08-18 |
2025-07-25 |
特兰斯吉恩公司 |
嵌合痘病毒
|